Epidemiology of carbapenem-resistant enterobacteriaceae in 7 US communities, 2012-2013

JAMA - Journal of the American Medical Association

Volumn 314, Issue 14, 2015, Pages 1479-1487

  Guh, Alice Y ^a   Bulens, Sandra N ^a   Mu, Yi ^a   Jacob, Jesse T ^b   Reno, Jessica ^c,d,e   Scott, Janine ^c,d,e   Wilson, Lucy E ^f   Vaeth, Elisabeth ^f   Lynfield, Ruth ^g   Shaw, Kristin M ^g   Vagnone, Paula M Snippes ^g   Bamberg, Wendy M ^h   Janelle, Sarah J ^h   Dumyati, Ghinwa ⁱ   Concannon, Cathleen ⁱ   Beldavs, Zintars ^j   Cunningham, Margaret ^j   Cassidy, P Maureen ^j   Phipps, Erin C ^k   Kenslow, Nicole ^k   Travis, Tatiana ^a   Lonsway, David ^a   Rasheed, J Kamile ^a   Limbago, Brandi M ^a   Kallen, Alexander J ^a   more..

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Georgia Emerging Infections Program   (United States)

^d Atlanta Research and Education Foundation Inc   (United States)

^e ATLANTA VA MEDICAL CENTER   (United States)

^f MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^g MINNESOTA DEPARTMENT OF HEALTH   (United States)

^h Colorado Department of Public Health and Environment ^*  (United States)

ⁱ UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^j OREGON HEALTH AUTHORITY   (United States)

^k UNIVERSITY OF NEW MEXICO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AZTREONAM; CARBAPENEM; CEPHALOSPORIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; UNITED STATES; URINE CULTURE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; CHILD; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GEORGIA; HEALTH SURVEY; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; SEX RATIO; URINE; VERY ELDERLY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CHILD; CHILD, PRESCHOOL; COLORADO; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; GEORGIA; HUMANS; INCIDENCE; INFANT; MALE; MARYLAND; MIDDLE AGED; MINNESOTA; NEW MEXICO; NEW YORK; OREGON; POPULATION SURVEILLANCE; SEX DISTRIBUTION;

EID: 84944144997     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.12480     Document Type: Article

References (29)

1. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60-67.
2. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228-236.
3. Guh AY, Limbago BM, Kallen AJ. Epidemiology and prevention ofcarbapenem-resistant Enterobacteriaceae in the United States. Expert Rev Anti Infect Ther. 2014;12(5):565-580.
4. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29(12):1099-1106.
5. Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis. 2009;49(2):271-274.
6. US Centers for Disease Control and Prevention. Tracking CRE. http://www.cdc.gov/hai/organisms/cre/TrackingCRE.html. Accessed February 18, 2015.
7. Association for Professionals in Infection Control and Epidemiology Inc. Summary ofstate CRE reporting requirements. http://www.apic.org/Resource-/TinyMceFileManager/Advocacy-PDFs/CRE-ReportingRequirements-Final.pdf. Accessed September 2, 2015.
8. US Census Bureau. Population estimates. http://www.census.gov/popest/data/index.html. Accessed February 18, 2015
9. Reno J, Schenck C, Scott J, et al. Querying automated antibiotic susceptibility testing instruments: a novel population-based active surveillance method for multidrug-resistant gram-negative bacilli. Infect Control Hosp Epidemiol. 2014;35(4):336-341.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
11. Rasheed JK, Kitchel B, Zhu W, et al. New Delhi metallo-p-lactamase-producing Enterobacteriaceae, United States. Emerg Infect Dis. 2013;19(6):870-878.
12. Kitchel B, Zhu W, Travis T, Limbago BM, Rasheed JK. Detection and evaluation of OXA-48 like carbapenemases by real-time PCR. In: Abstracts of the 53rd Meeting ICAAC; Denver, Colorado; September 10-13, 2013. Abstract D-1139.
13. Schoenbach VJ, Rosamond WD. Understanding the fundamentals of epidemiology-an evolving text: standardization of rates and ratios. http://www.epidemiolog.net/evolving/Standardization.pdf. Accessed February 20, 2015.
14. Stone ND, Ashraf MS, Calder J, et al; Society for Healthcare Epidemiology Long-Term Care Special Interest Group. Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteria. Infect Control Hosp Epidemiol. 2012;33(10):965-977.
15. US Centers for Disease Control and Prevention. Urinary tract infection (UTI) event for long-term care facilities. http://www.cdc.gov/nhsn/PDFs/LTC/LTCF-UTI-protocol-current.pdf. Accessed February 18, 2015.
16. Dantes R, Mu Y, Belflower R, et al; Emerging Infections Program-Active Bacterial Core Surveillance MRSA Surveillance Investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013;173(21):1970-1978.
17. Cleveland AA, Farley MM, Harrison LH, et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis. 2012;55(10):1352-1361.
18. Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825-834.
19. US Centers for Disease Control and Prevention. Guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). http://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf. Accessed April 24, 2015.
20. Centers for Disease Control and Prevention. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep. 2013;62(9):165-170.
21. Prabaker K, Lin MY, McNally M, et al; US Centers for Disease Control and Prevention Epicenters Program. Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol. 2012;33(12):1193-1199.
22. Lin MY, Lyles-Banks RD, Lolans K, et al; US Centers for Disease Control and Prevention Epicenters Program. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2013;57(9):1246-1252.
23. Chitnis AS, Caruthers PS, Rao AK, et al. Outbreak of carbapenem-resistant Enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol. 2012;33(10):984-992.
24. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK; US Centers for Disease Control and Prevention Epicenter Program. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2011;53(6):532-540.
25. Doi Y, Park YS, Rivera JI, et al. Community-associated extended-spectrum ß-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56(5):641-648.
26. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother. 2005;56(1):52-59.
27. Rodríguez-Baño J, Alcalá J, Cisneros JM, et al. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. J Antimicrob Chemother. 2009;63(4):781-784.
28. Banerjee R, Strahilevitz J, Johnson JR, et al. Predictors and molecular epidemiology of community-onset extended-spectrum ß-lactamase-producing Escherichia coli infection in a Midwestern community. Infect Control Hosp Epidemiol. 2013;34(9):947-953.
29. Centers for Disease Control and Prevention. Carbapenem-resistant Klebsiella pneumoniae associated with a long-term care facility-West Virginia, 2009-2011. MMWR Morb Mortal Wkly Rep. 2011;60(41):1418-1420.